ES2242869T3 - Derivados sustituidos de c-furan-2-ilmetilamina y c-tiofen-2-ilmetilamina. - Google Patents

Derivados sustituidos de c-furan-2-ilmetilamina y c-tiofen-2-ilmetilamina.

Info

Publication number
ES2242869T3
ES2242869T3 ES02743057T ES02743057T ES2242869T3 ES 2242869 T3 ES2242869 T3 ES 2242869T3 ES 02743057 T ES02743057 T ES 02743057T ES 02743057 T ES02743057 T ES 02743057T ES 2242869 T3 ES2242869 T3 ES 2242869T3
Authority
ES
Spain
Prior art keywords
alkyl
oetyl
mean
independently
enantiomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02743057T
Other languages
English (en)
Spanish (es)
Inventor
Corinna Maul
Michael Przewosny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Chemie Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH, Chemie Gruenenthal GmbH filed Critical Gruenenthal GmbH
Application granted granted Critical
Publication of ES2242869T3 publication Critical patent/ES2242869T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES02743057T 2001-05-22 2002-05-21 Derivados sustituidos de c-furan-2-ilmetilamina y c-tiofen-2-ilmetilamina. Expired - Lifetime ES2242869T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10125145A DE10125145A1 (de) 2001-05-22 2001-05-22 Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
DE10125145 2001-05-22

Publications (1)

Publication Number Publication Date
ES2242869T3 true ES2242869T3 (es) 2005-11-16

Family

ID=7685874

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02743057T Expired - Lifetime ES2242869T3 (es) 2001-05-22 2002-05-21 Derivados sustituidos de c-furan-2-ilmetilamina y c-tiofen-2-ilmetilamina.

Country Status (17)

Country Link
US (2) US6878740B2 (pl)
EP (1) EP1392670B1 (pl)
JP (1) JP2004532246A (pl)
AR (1) AR035982A1 (pl)
AT (1) ATE299873T1 (pl)
AU (1) AU2002338989B2 (pl)
CA (1) CA2448038C (pl)
DE (2) DE10125145A1 (pl)
DK (1) DK1392670T3 (pl)
ES (1) ES2242869T3 (pl)
HU (1) HUP0401162A3 (pl)
MX (1) MXPA03010601A (pl)
PE (1) PE20021099A1 (pl)
PL (1) PL367535A1 (pl)
PT (1) PT1392670E (pl)
SI (1) SI1392670T1 (pl)
WO (1) WO2002094802A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
CN102482249B (zh) 2009-07-08 2016-06-08 德米拉(加拿大)公司 用于治疗皮肤病症或疾病状态的tofa类似物
KR20160101928A (ko) * 2013-11-22 2016-08-26 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 흡입 약제
KR101844984B1 (ko) * 2016-05-31 2018-04-03 한림대학교 산학협력단 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN112521357B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3816457A (en) * 1973-01-05 1974-06-11 Richardson Merrell Inc Lactamimide derivatives
US3890445A (en) * 1973-01-05 1975-06-17 Richardson Merrell Inc Lactamimide derivatives useful as hypoglycemic agents
WO2001068816A1 (en) 2000-03-13 2001-09-20 Smithkline Beecham Corporation Human histamine h3 gene variant-3
DE10012820A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine
DE10059864A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate

Also Published As

Publication number Publication date
EP1392670B1 (de) 2005-07-20
PE20021099A1 (es) 2003-01-25
CA2448038C (en) 2010-09-28
HUP0401162A2 (hu) 2004-10-28
AU2002338989B2 (en) 2007-06-07
CA2448038A1 (en) 2002-11-28
US6878740B2 (en) 2005-04-12
PL367535A1 (pl) 2005-02-21
MXPA03010601A (es) 2004-03-09
ATE299873T1 (de) 2005-08-15
DE10125145A1 (de) 2002-11-28
PT1392670E (pt) 2005-10-31
HUP0401162A3 (en) 2007-05-02
EP1392670A1 (de) 2004-03-03
US20040152734A1 (en) 2004-08-05
JP2004532246A (ja) 2004-10-21
US20050148550A1 (en) 2005-07-07
WO2002094802A1 (de) 2002-11-28
DE50203686D1 (en) 2005-08-25
DK1392670T3 (da) 2005-08-08
SI1392670T1 (sl) 2005-12-31
US7317034B2 (en) 2008-01-08
AR035982A1 (es) 2004-07-28

Similar Documents

Publication Publication Date Title
ES2198355T3 (es) Nuevos derivados de t-butil-(7-metil-imidazo-(1,2-a)-piridin-3-il)-amina, procedimiento para su preparacion y las composiciones farmaceuticas que los contienen.
AU2010339689B2 (en) Quaternary ammonium salt prodrugs
FI107158B (fi) Menetelmä kondensoitujen indolikarboksylaatti- ja indolikarboksiamidijohdannaisten valmistamiseksi
RO117791B1 (ro) Derivati ai acidului 1-(2-oxo-acetil)-piperidin-2-carboxilic, procedeu de obtinere, compozitie farmaceutica care ii contine si metoda de tratament
KR20140140625A (ko) 베타-락타마제 억제제로서의 헤테로비시클릭 화합물
PT100785A (pt) Utilizacao de compostos, por exemplo indole-3-carboxilatos, para a producao de medicamentos, compostos ai utilizados e composicoes farmaceuticas que os contem.
KR20110044221A (ko) 탄산 퀴누클리딘 유도체 및 그것의 의학적 조성물
ES2242869T3 (es) Derivados sustituidos de c-furan-2-ilmetilamina y c-tiofen-2-ilmetilamina.
TW201514150A (zh) 組蛋白去乙醯酶抑制劑及組成物，暨其使用之方法
PT842178E (pt) Furopiridina tienopiridina pirrolopiridina e compostos relacionados de pirimidina piridazina e triazina uteis no controlo da transmissao sinaptica quimica
HUP0401302A2 (hu) Helyettesített imidazo[1,2-a]piridin-vegyületek felhasználása gyógyszerként
EP0213499A2 (de) Aminosäure-Derivate, Verfahren zu ihrer Herstellung und Verwendung
ES2344842T3 (es) Compuestos de quinuclidina que tienen un grupo amonio cuaternario, su metodo de preparacion y uso como agentes bloqueantes de la acetilcolina.
ES2284973T3 (es) Derivados de 2-pirrolidin-2-il-1h-indol sustituidos para el tratamiento de la migraña.
PT776899E (pt) Intermediarios e seu uso para a preparacao de bisindolilmaleimidas com pontes n,n
US7230103B2 (en) Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
ES2239168T3 (es) 3,4-dihidropirimido(1,2-a)pirimidina y 3,4-dihidropirazin(1,2-a)pirimidina sustituidas.
WO2004087172A1 (ja) Ｔ型カルシウムチャネル阻害剤
JP2005511694A6 (ja) 置換された２−ピロリジン−２−イル−１ｈ−インドール誘導体
HK40121587A (zh) 拮抗lpa1受体的脲化合物
HK40066527B (zh) 拮抗lpa1受体的脲化合物
HK40066527A (zh) 拮抗lpa1受体的脲化合物
HUP0400800A2 (hu) Helyettesített 5,6,6a,11b-tetrahidro-7-oxa-5-aza-benzo[c]fluorén-6-karbonsav-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
WO1996027595A1 (en) Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias
KR20050024450A (ko) 신규한 퀴누클리딘 아미드 유도체